Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Additional information (Details)

v3.20.2
Summary of Significant Accounting Policies - Additional information (Details)
 3 Months Ended
Sep. 30, 2020
USD ($)
customer
item
Sep. 30, 2019
USD ($)
customer
Jun. 30, 2020
USD ($)
Summary Of Significant Accounting Policies [Line Items]      
Number Of Lines Of Business | item 3    
Contract liabilities (or deferred revenue) $ 1,370,000   $ 1,810,000
Goodwill and Intangible Asset Impairment 0 $ 0  
Revenues From Grants 0 0  
Work in process 843,000   798,000
Revenues 410,000 108,000  
Contract with Customer, Liability, Revenue Recognized 311,800 $ 93,000  
Contract with Customer, Asset, Net, Current $ 0   0
Dividend rate 0.00%    
Amount in excess of insured limit $ 57,162,000   $ 54,680,000
Number of major customers | customer 2 3  
Transferred over Time      
Summary Of Significant Accounting Policies [Line Items]      
Revenues $ 0 $ 47,000  
Transferred at Point in Time      
Summary Of Significant Accounting Policies [Line Items]      
Revenues $ 410,000 $ 61,000  
Corteva Agriscience | Revenue      
Summary Of Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage 50.50% 14.10%  
AzarGen Biotechnologies | Revenue      
Summary Of Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage 49.50%    
CC-Pharming | Revenue      
Summary Of Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage   43.70%  
Lung Biotechnology | Revenue      
Summary Of Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage   42.20%  
Minimum      
Summary Of Significant Accounting Policies [Line Items]      
Estimated useful life, Fixed assets P3Y    
Maximum      
Summary Of Significant Accounting Policies [Line Items]      
Estimated useful life, Fixed assets P15Y    
Patents      
Summary Of Significant Accounting Policies [Line Items]      
Finite-Lived Intangible Asset, Useful Life 10 years    
Intellectual Property | Minimum      
Summary Of Significant Accounting Policies [Line Items]      
Finite-Lived Intangible Asset, Useful Life 16 years    
Intellectual Property | Maximum      
Summary Of Significant Accounting Policies [Line Items]      
Finite-Lived Intangible Asset, Useful Life 23 years